Artwork

Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development

28:49
 
Share
 

Manage episode 464934237 series 2304454
Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases.

Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine.

Show Notes

n=1 Collaborative

Rare Disease | Charles River

Rare Disease Research for Drug Development

Repurposing Drugs for Rare Disease

S4 E07: Free For Life: The Story of N-Lorem Foundation

  continue reading

92 episodes

Artwork
iconShare
 
Manage episode 464934237 series 2304454
Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases.

Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine.

Show Notes

n=1 Collaborative

Rare Disease | Charles River

Rare Disease Research for Drug Development

Repurposing Drugs for Rare Disease

S4 E07: Free For Life: The Story of N-Lorem Foundation

  continue reading

92 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play